Clinical Trial

Endothelial Glycocalyx Damage in Brain Death Organ Donors

Recruiting
View on ClinicalTrials.gov →
Summary
The study aims the assessment of endothelial glycocalyx (EG) degradation in deceased organ donors. There is a lack of organs for the transplantation program. By the description of the EG status, we can open room for organ optimization before transplantation and improve the organ function after transplantation in marginal donors.
Protocol Amendment History 4 amendments
This ClinicalTrials.gov record has been amended 4 times since 2022-11-05; most recent amendment 2026-04-27.
Status change: Active, Not Recruiting → Recruiting 2026-04-27
Status change: Recruiting → Active, Not Recruiting 2025-03-24
Trial Details
NCT Number NCT05609123
Lead Sponsor University Hospital Hradec Kralove
Conditions Brain Damage Due to Hypoxia, Organ Donors, Organ Transplant Failure or Rejection
Enrollment 100 participants
Start Date 2022-01-01
Primary Completion 2027-12-31 (estimated)
Study Completion 2027-12-31 (estimated)
Updated on ClinicalTrials.gov 2026-05-01